Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Heart Journal Plus : Cardiology Research and Practice|May 11, 2026
Psychosocial factors, guideline-directed medical therapy, and healthcare resource use among patients newly diagnosed with heart failure in the United StatesStephen J Greene, Vishal Bali, Catelyn Coyle, et al.The Journal of Biological Chemistry|April 2, 2011
The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activityBartosz J Zieba, Mykhaylo V Artamonov, Li Jin, et al.Journal of the American Heart Association|June 9, 2026
Barriers to Optimization of Medical Therapy and the Role of Checklist-Based Decision Support in Heart FailureBrett M Montelaro, Edward Woods, Candace D Speight, et al.Hypertension (Dallas, Tex. : 1979)|December 7, 2016
Chronic Inhibition of Renal Outer Medullary Potassium Channel Not Only Prevented but Also Reversed Development of Hypertension and End-Organ Damage in Dahl Salt-Sensitive RatsXiaoyan Zhou, Michael J Forrest, Wanda Sharif-Rodriguez, et al.Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.Journal of Medicinal Chemistry|January 21, 2014
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladderChristopher R Moyes, Richard Berger, Stephen D Goble, et al.Journal of Medicinal Chemistry|December 29, 2015
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive BladderScott D Edmondson, Cheng Zhu, Nam Fung Kar, et al.Pageof 2